Natasha Ballard, MD
Family Medicine · Chattanooga, TNNPI 1023288743
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 46.9% of the total. Reporting peaked in 2021 at $278 and has fallen 62.3% since, to $105 in 2025.
Across 57 payments — averaging $14.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$380
- Genentech USA, Inc.$183
- Sanofi$88
- Abbott$58
- Zyla Life Sciences, Inc.$27
- Cue Health Inc.$24
- plus $49 from 3 others
Across 840 payments — averaging $6825.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$2M
- Bavarian Nordic A/s$1.5M
- Abbott$639K
- Novavax Inc$477K
- Seqirus USA Inc$360K
- Sanofi Pasteur Inc.$260K
- plus $512K from 12 others
What the payments were for
- Food & beverage$809100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $380 |
| Genentech USA, Inc. | 10 | $183 |
| Sanofi | 2 | $88 |
| Abbott | 2 | $58 |
| Zyla Life Sciences, Inc. | 2 | $27 |
| Cue Health Inc. | 1 | $24 |
| Boston Scientific | 2 | $23 |
| Lilly USA, LLC | 1 | $17 |
| Pfizer | 1 | $10 |
How this compares
$809 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 16 | $127 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chattanooga
- Ellen ClelandChattanooga$38K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Meredith SchweitzerAntioch$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.